Description

LA-Bac8c is a Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. LA-Bac8c inhibits S. aureus, MRSA, S. epidermidis, E. coli, and P. aeruginosa with MICs of 1, 4, 8, 8, and 8 μg/mL[1].—COVID-19-immunoregulation–C65H102N20O9S2—-[1]Wenya Zhou, et al. Lipoic acid modified antimicrobial peptide with enhanced antimicrobial properties. Bioorg Med Chem. 2020 Oct 1;28(19):115682.—-1371.76—-O=C([C@@H](NC(CCCC[C@@H]1CCSS1)=O)CCCNC(N)=N)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CC2=CNC3=CC=CC=C23)=O)[C@H](CC)C)=O)C(C)C)=O)CC4=CNC5=CC=CC=C45)=O)[C@H](CC)C–Infection–10 mM in DMSO–Antibiotic;Bacterial—-Anti-infection–Peptides